Plasmin(ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: Role of plasmin-activated signals

Journal of the American Society of Nephrology

Volumn 18, Issue 3, 2007, Pages 846-859

  Zhang, Guoqiang ^a   Kernan, Kelly A ^a   Collins, Sarah J ^a   Cai, Xiaohe ^a   López Guisa, Jesús M ^a   Degen, Jay L ^b   Shvil, Yigal ^c   Eddy, Allison A ^a,d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^c HEBREW UNIVERSITY   (Israel)

^d SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CELL PROTEIN; COLLAGEN; FIBROBLAST SPECIFIC PROTEIN 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PEPDUCIN; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEINASE ACTIVATED RECEPTOR 1; SIGNAL PEPTIDE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UO 126; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CELL CULTURE; CELL TRANSFORMATION; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; GENE SILENCING; GENOTYPE; KIDNEY EPITHELIUM; KIDNEY FIBROSIS; MESENCHYME CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; URETER OBSTRUCTION;

EID: 33947233187     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006080886     Document Type: Article

References (55)

1. Eddy AA: Progression in chronic kidney disease. Adv Chronic Kidney Dis 12: 353-365, 2005
2. Chai Q, Krag S, Chai S, Ledet T, Wogensen L: Localisation and phenotypical characterisation of collagen-producing cells in TGF-beta1-induced renal interstitial fibrosis. Histochem Cell Biol 119: 267-280, 2003
3. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110: 341-350, 2002
4. Kalluri R, Neilson EG: Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776-1784, 2003
5. Wheelock MJ, Johnson KR: Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol 19: 207-235, 2003
6. Zavadil J, Bitzer M, Liang D, Yang YC, Massimi A, Kneitz S, Piek E, Bottinger EP: Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc Natl Acad Sci U S A 98: 6686-6691, 2001
7. Yang J, Shultz RW, Mars WM, Wegner RE, Li Y, Dai C, Nejak K, Liu Y: Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. J Clin Invest 110: 1525-1538, 2002
8. Bugge TH, Flick MJ, Daugherty CC, Degen JL: Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev 9: 794-807, 1995
9. Romer J, Bugge TH, Pyke C, Lund LR, Flick MJ, Degen JL, Dano K: Plasminogen and wound healing. Nat Med 2: 725, 1996
10. Nagase H: Activation mechanisms of matrix metalloproteinases. Biol Chem 378: 151-160, 1997
11. Kasai S, Arimura H, Nishida M, Suyama T: Primary structure of single-chain pro-urokinase. J Biol Chem 260: 12382-12389, 1985
12. Eddy AA: Plasminogen activator inhibitor-1 and the kidney. Am J Physiol Renal Physiol 283: F209-F220, 2002
13. Matsushima K, Taguchi M, Kovacs EJ, Young HA, Oppenheim JJ: Intracellular localization of human monocyte associated interleukin 1 (IL 1) activity and release of biologically active IL 1 from monocytes by trypsin and plasmin. J Immunol 136: 2883-2891, 1986
14. Edgtton KL, Gow RM, Kelly DJ, Carmeliet P, Kitching AR: Plasmin is not protective in experimental renal interstitial fibrosis. Kidney Int 66: 68-76, 2004
15. Ryniers F, Stove C, Goethals M, Brackenier L, Noe V, Bracke M, Vandekerckhove J, Mareel M, Bruyneel E: Plasmin produces an E-cadherin fragment that stimulates cancer cell invasion. Biol Chem 383: 159-165, 2002
16. Eddy AA, Fogo AB: Plasminogen activator inhibitor-1 in chronic kidney disease: Evidence and mechanisms of action. J Am Soc Nephrol 17: 2999-3012, 2006
17. Winram SB, Lottenberg R: The plasmin-binding protein Plr of group A streptococci is identified as glyceraldehyde-3-phosphate dehydrogenase. Microbiology 142: 2311-2320, 1996
18. Yamakami K, Yoshizawa N, Wakabayashi K, Takeuchi A, Tadakuma T, Boyle MD: The potential role for nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. Methods 21: 185-197, 2000
19. Oda T, Yamakami K, Omasu F, Suzuki S, Miura S, Sugisaki T, Yoshizawa N: Glomerular plasmin-like activity in relation to nephritis-associated plasmin receptor in acute post-streptococcal glomerulonephritis. J Am Soc Nephrol 16: 247-254, 2005
20. Coughlin SR: How the protease thrombin talks to cells. Proc Natl Acad Sci U S A 96: 11023-11027, 1999
21. Pendurthi UR, Ngyuen M, Andrade-Gordon P, Petersen LC, Rao LV: Plasmin induces Cyr61 gene expression in fibroblasts via protease-activated receptor-1 and p44/42 mitogen-activated protein kinase-dependent signaling pathway. Arterioscler Thromb Vasc Biol 22: 1421-1426, 2002
22. Burysek L, Syrovets T, Simmet T: The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and janus kinase (JAK)/STAT signaling pathways. J Biol Chem 277: 33509-33517, 2002
23. Zhang G, Kim H, Cai X, Lopez-Guisa J, Alpers C, Liu Y, Carmeliet P, Eddy A: Urokinase receptor deficiency accelerates fibrosis in obstructive nephropathy. J Am Soc Nephrol 14: 1254-1271, 2003
24. Kivirikko KI, Laitinen O, Prockop DJ: Modifications of a specific assay for hydroxyproline in urine. Anal Biochem 19: 249-255, 1967
25. Zhang G, Kim H, Cai X, Lopez-Guisa J, Carmeliet P, Eddy A: Urokinase receptor modulates cellular and angiogenic responses in obstructive uropathy. J Am Soc Nephrol 14: 1234-1253, 2003
26. Qian SW, Kondaiah P, Roberts AB, Sporn MB: cDNA cloning by PCR of rat transforming growth factor beta-1. Nucleic Acids Res 18: 3059, 1990
27. Ishii K, Hein L, Kobilka B, Coughlin SR: Kinetics of thrombin receptor cleavage on intact cells. Relation to signaling. J Biol Chem 268: 9780-9786, 1993
28. Iwano M, Fischer A, Okada H, Plieth D, Xue C, Danoff TM, Neilson EG: Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts. Mol Ther 3: 149-159, 2001
29. Zhang G, Cai X, Lopez-Guisa JM, Collins SJ, Eddy AA: Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: Actions of an alternative urokinase receptor and LDL receptor-related protein. J Am Soc Nephrol 15: 2090-2102, 2004
30. Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, Rifkin DB: An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 216: 276-284, 1994
31. Haverty TP, Kelly CP, Hines WH, Amenta PS, Watanabe M, Harper RA, Kefalides NA, Neilson EG: Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis. J Cell Biol 107: 1359-1368, 1988
32. Covic L, Misra M, Badar J, Singh C, Kuliopulos A: Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation. Nat Med 8: 1161-1165, 2002
33. Andrade-Gordon P, Maryanoff BE, Derian CK, Zhang HC, Addo MF, Darrow AL, Eckardt AJ, Hoekstra WJ, McComsey DF, Oksenberg D, Reynolds EE, Santulli RJ, Scarborough RM, Smith CE, White KB: Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor. Proc Natl Acad Sci U S A 96: 12257-12262, 1999
34. Boire A, Covic L, Agarwal A, Jacques S, Sherifi S, Kuliopulos A: PARI is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120: 303-313, 2005
35. Tarui T, Majumdar M, Miles LA, Ruf W, Takada Y: Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin. J Biol Chem 277: 33564-33570, 2002
36. Majumdar M, Tarui T, Shi B, Akakura N, Ruf W, Takada Y: Plasmin-induced migration requires signaling through protease-activated receptor 1 and integrin alpha(9)beta(1). J Biol Chem 279: 37528-37534, 2004
37. Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W: Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296: 1880-1882, 2002
38. Blanc-Brude OP, Archer F, Leoni P, Derian C, Bolsover S, Laurent GJ, Chambers RC: Factor Xa stimulates fibroblast procollagen production, proliferation, and calcium signaling via PAR1 activation. Exp Cell Res 304: 16-27, 2005
39. Oikonomopoulou K, Hansen KK, Saifeddine M, Tea I, Blaber M, Blaber SI, Scarisbrick I, Andrade-Gordon P, Cottrell GS, Bunnett NW, Diamandis EP, Hollenberg MD: Proteinase-activated receptors (PARs), targets for kallikrein signaling. J Biol Chem 281: 32095-32112, 2006
40. Cunningham MA, Rondeau E, Chen X, Coughlin SR, Holdsworth SR, Tipping PG: Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med 191: 455-462, 2000
41. Vu TK, Hung DT, Wheaton VI, Coughlin SR: Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64: 1057-1068, 1991
42. McLaughlin JN, Shen L, Holinstat M, Brooks JD, Dibenedetto E, Hamm HE: Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1. J Biol Chem 280: 25048-25059, 2005
43. Rhyu DY, Yang Y, Ha H, Lee GT, Song JS, Uh ST, Lee HB: Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 16: 667-675, 2005
44. Yang M, Huang H, Li J, Li D, Wang H: Tyrosine phosphorylation of the LDL receptor-related protein (LRP) and activation of the ERK pathway are required for connective tissue growth factor to potentiate myofibroblast differentiation. FASEB J 18: 1920-1921, 2004
45. Masaki T, Stambe C, Hill PA, Dowling J, Atkins RC, Nikolic-Paterson DJ: Activation of the extracellular-signal regulated protein kinase pathway in human glomerulopathies. J Am Soc Nephrol 15: 1835-1843, 2004
46. Platanias LC: Map kinase signaling pathways and hematologic malignancies. Blood 101: 4667-4679, 2003
47. Roux PP, Blenis J: ERK and p38 MAPK-activated protein kinases: A family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68: 320-344, 2004
48. Stambe C, Atkins RC, Tesch GH, Masaki T, Schreiner GF, Nikolic-Paterson DJ: The role of p38alpha mitogen-activated protein kinase activation in renal fibrosis. J Am Soc Nephrol 15: 370-379, 2004
49. Jenkins RG, Su X, Su G, Scotton CJ, Camerer E, Laurent GJ, Davis GE, Chambers RC, Matthay MA, Sheppard D: Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest 116: 1606-1614, 2006
50. Tamaki K, Okuda S, Miyazono K, Nakayama M, Fujishima M: Matrix-associated latent TGF-beta with latent TGF-beta binding protein in the progressive process in adriamycin-induced nephropathy. Lab Invest 73: 81-89, 1995
51. Ellenrieder V, Hendler SF, Boeck W, Seufferlein T, Menke A, Ruhland C, Adler G, Gress TM: Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res 61: 4222-4228, 2001
52. Roztocil E, Nicholl SM, Galaria II, Davies MG: Plasmin-induced smooth muscle cell proliferation requires epidermal growth factor activation through an extracellular pathway. Surgery 138: 180-186, 2005
53. Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY: Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 56: 1455-1467, 1999
54. Dominguez-Salazar E, Bateman HL, Rissman EF: Background matters: The effects of estrogen receptor alpha gene disruption on male sexual behavior are modified by background strain. Horm Behav 46: 482-490, 2004
55. Morice E, Denis C, Giros B, Nosten-Bertrand M: Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background. Eur J Neurosci 20: 120-126, 2004